Six-day randomized safety trial of intravaginal lime juice

Christine K. Mauck, Susan A. Ballagh, Mitchell D Creinin, Debra H. Weiner, Gustavo F. Doncel, Raina N. Fichorova, Jill L. Schwartz, Neelima Chandra, Marianne M. Callahan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Nigerian women reportedly apply lime juice intravaginally to protect themselves against HIV. In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina. Forty-seven women were randomized to apply water or lime juice (25%, 50%, or undiluted.) intravaginally twice daily for two 6-day intervals, separated by a 3-week, washout period. Product application, also was randomized: during 1 interval, product was applied using a saturated tampon and in the other by douche. Vaginal pH, symptoms, signs of irritation observed via naked eye examination, and colposcopy, microflora, and markers of inflammation, in cervicovaginal lavages were evaluated, after 1 hour and on days 3 and 7. The largest reduction in pH was about one-half a pH unit, seen 1 hour after douching with 100% lime juice. We observed a dose-dependent pattern of symptoms and clinical and laboratory findings that were consistent with, a compromised vaginal barrier function. The brief reduction in pH after vaginal lime juice application is unlikely to be virucidal in the presence of semen. Lime juice is unlikely to protect against HIV and. may actually be harmful.

Original languageEnglish (US)
Pages (from-to)243-250
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume49
Issue number3
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Safety
Therapeutic Irrigation
HIV
Colposcopy
Vagina
lime
Semen
Signs and Symptoms
Randomized Controlled Trials
Inflammation
Water

Keywords

  • Clinical trial
  • HIV
  • Lime
  • Microbicide
  • Safety
  • Vaginal

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Mauck, C. K., Ballagh, S. A., Creinin, M. D., Weiner, D. H., Doncel, G. F., Fichorova, R. N., ... Callahan, M. M. (2008). Six-day randomized safety trial of intravaginal lime juice. Journal of Acquired Immune Deficiency Syndromes, 49(3), 243-250. https://doi.org/10.1097/QAI.0b013e318186eae7

Six-day randomized safety trial of intravaginal lime juice. / Mauck, Christine K.; Ballagh, Susan A.; Creinin, Mitchell D; Weiner, Debra H.; Doncel, Gustavo F.; Fichorova, Raina N.; Schwartz, Jill L.; Chandra, Neelima; Callahan, Marianne M.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 49, No. 3, 11.2008, p. 243-250.

Research output: Contribution to journalArticle

Mauck, CK, Ballagh, SA, Creinin, MD, Weiner, DH, Doncel, GF, Fichorova, RN, Schwartz, JL, Chandra, N & Callahan, MM 2008, 'Six-day randomized safety trial of intravaginal lime juice', Journal of Acquired Immune Deficiency Syndromes, vol. 49, no. 3, pp. 243-250. https://doi.org/10.1097/QAI.0b013e318186eae7
Mauck, Christine K. ; Ballagh, Susan A. ; Creinin, Mitchell D ; Weiner, Debra H. ; Doncel, Gustavo F. ; Fichorova, Raina N. ; Schwartz, Jill L. ; Chandra, Neelima ; Callahan, Marianne M. / Six-day randomized safety trial of intravaginal lime juice. In: Journal of Acquired Immune Deficiency Syndromes. 2008 ; Vol. 49, No. 3. pp. 243-250.
@article{0bda50063cb74c9a9a517fa5b3621972,
title = "Six-day randomized safety trial of intravaginal lime juice",
abstract = "Nigerian women reportedly apply lime juice intravaginally to protect themselves against HIV. In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina. Forty-seven women were randomized to apply water or lime juice (25{\%}, 50{\%}, or undiluted.) intravaginally twice daily for two 6-day intervals, separated by a 3-week, washout period. Product application, also was randomized: during 1 interval, product was applied using a saturated tampon and in the other by douche. Vaginal pH, symptoms, signs of irritation observed via naked eye examination, and colposcopy, microflora, and markers of inflammation, in cervicovaginal lavages were evaluated, after 1 hour and on days 3 and 7. The largest reduction in pH was about one-half a pH unit, seen 1 hour after douching with 100{\%} lime juice. We observed a dose-dependent pattern of symptoms and clinical and laboratory findings that were consistent with, a compromised vaginal barrier function. The brief reduction in pH after vaginal lime juice application is unlikely to be virucidal in the presence of semen. Lime juice is unlikely to protect against HIV and. may actually be harmful.",
keywords = "Clinical trial, HIV, Lime, Microbicide, Safety, Vaginal",
author = "Mauck, {Christine K.} and Ballagh, {Susan A.} and Creinin, {Mitchell D} and Weiner, {Debra H.} and Doncel, {Gustavo F.} and Fichorova, {Raina N.} and Schwartz, {Jill L.} and Neelima Chandra and Callahan, {Marianne M.}",
year = "2008",
month = "11",
doi = "10.1097/QAI.0b013e318186eae7",
language = "English (US)",
volume = "49",
pages = "243--250",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Six-day randomized safety trial of intravaginal lime juice

AU - Mauck, Christine K.

AU - Ballagh, Susan A.

AU - Creinin, Mitchell D

AU - Weiner, Debra H.

AU - Doncel, Gustavo F.

AU - Fichorova, Raina N.

AU - Schwartz, Jill L.

AU - Chandra, Neelima

AU - Callahan, Marianne M.

PY - 2008/11

Y1 - 2008/11

N2 - Nigerian women reportedly apply lime juice intravaginally to protect themselves against HIV. In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina. Forty-seven women were randomized to apply water or lime juice (25%, 50%, or undiluted.) intravaginally twice daily for two 6-day intervals, separated by a 3-week, washout period. Product application, also was randomized: during 1 interval, product was applied using a saturated tampon and in the other by douche. Vaginal pH, symptoms, signs of irritation observed via naked eye examination, and colposcopy, microflora, and markers of inflammation, in cervicovaginal lavages were evaluated, after 1 hour and on days 3 and 7. The largest reduction in pH was about one-half a pH unit, seen 1 hour after douching with 100% lime juice. We observed a dose-dependent pattern of symptoms and clinical and laboratory findings that were consistent with, a compromised vaginal barrier function. The brief reduction in pH after vaginal lime juice application is unlikely to be virucidal in the presence of semen. Lime juice is unlikely to protect against HIV and. may actually be harmful.

AB - Nigerian women reportedly apply lime juice intravaginally to protect themselves against HIV. In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina. Forty-seven women were randomized to apply water or lime juice (25%, 50%, or undiluted.) intravaginally twice daily for two 6-day intervals, separated by a 3-week, washout period. Product application, also was randomized: during 1 interval, product was applied using a saturated tampon and in the other by douche. Vaginal pH, symptoms, signs of irritation observed via naked eye examination, and colposcopy, microflora, and markers of inflammation, in cervicovaginal lavages were evaluated, after 1 hour and on days 3 and 7. The largest reduction in pH was about one-half a pH unit, seen 1 hour after douching with 100% lime juice. We observed a dose-dependent pattern of symptoms and clinical and laboratory findings that were consistent with, a compromised vaginal barrier function. The brief reduction in pH after vaginal lime juice application is unlikely to be virucidal in the presence of semen. Lime juice is unlikely to protect against HIV and. may actually be harmful.

KW - Clinical trial

KW - HIV

KW - Lime

KW - Microbicide

KW - Safety

KW - Vaginal

UR - http://www.scopus.com/inward/record.url?scp=58149164567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149164567&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e318186eae7

DO - 10.1097/QAI.0b013e318186eae7

M3 - Article

C2 - 18845958

AN - SCOPUS:58149164567

VL - 49

SP - 243

EP - 250

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 3

ER -